Skip to Main Content

states

STAT’s team of health and medicine reporters are covering the latest life sciences and health tech news from across the country. We have reporters based in California, Massachusetts, New York, New Jersey, Ohio, Indiana, Minnesota, and Washington D.C., covering the latest health care news whereever it hits. The coverage on this page includes our best stories about state policymakers, state legislative sessions, and other major deals in states like Texas, Florida, Pennsylvania, and Illinois.

Latest

Pharmalot Ed Silverman

STAT Plus: Pharma companies and their allies seek to exempt orphan drugs from state pricing limits

Pharmalot Ed Silverman

STAT Plus: Pharma loses a key battle over a state law concerning 340B pharmacies

Health Nicholas Florko

Delta 8 THC use reported by 11% of high school seniors

Biotech Robert Weisman — Boston Globe

STAT Plus: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership

First Opinion Allen Goldberg

IVF bans like Alabama’s could cost the lives of children already born

First Opinion Joel B. Zivot

A new Louisiana capital-punishment bill would fundamentally alter physician licensing

Pharmalot Ed Silverman

STAT Plus: Oregon suspends a portion of its drug transparency law found to be unconstitutional

Pharmalot Rachel Cohrs and Ed Silverman

STAT Plus: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado

All Coverage

Business Brittany Trang

STAT Plus: States are ramping up scrutiny of health transactions, as more provider groups look for buyers

Exclusive Megan Molteni

Texas Medicaid agrees to fully cover gene therapy for Afghan refugees’ infant

advertisement

Health Olivia Goldhill

STAT Plus: Texas Medical Board under pressure to define emergency exception to abortion ban

First Opinion Joel B. Zivot

I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

First Opinion Tina Shah and Devika Bhushan

Other states should follow New Jersey’s lead on prior authorization reform

Health Megan Molteni

In partial reversal, Texas Medicaid greenlights first step in gene therapy for Afghan refugees’ infant son

Politics Olivia Goldhill and Annalisa Merelli

STAT Plus: Advocates expect Supreme Court Idaho abortion decision to fuel efforts to further restrict access

Politics John Wilkerson

Biden’s FDA is letting Ron DeSantis import cheaper drugs from Canada. Who gets to take credit?

Health Care Inc. Bob Herman

UnitedHealth’s rehab restrictions, Texas medical school drama, and health care’s biggest profits

Special Report Rachel Cohrs

STAT Plus: Texas taxpayers wanted to help the poor get health care. Instead, they’re funding a medical school at a wealthy university

Hospitals Rachel Cohrs

STAT Plus: Inside Ascension’s legal fight with a Texas agency over caring for the poor

Politics Brittany Trang

STAT Plus: 3 health policies states are taking on in 2024

A STAT Investigation Nicholas Florko

STAT Plus: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny

First Opinion Abigail Wilpers

Exceptions to abortion restrictions often fail people like Kate Cox whose babies are sure to die

Pharmalot Ed Silverman

STAT Plus: Vertex gets a win as Colorado board leaves cystic fibrosis drug off a list of unaffordable medicines

First Opinion Anjali Garg and Amanda Ruth

Having a child with complex medical needs is hard enough. Navigating the health care system makes it worse

Pharmalot Ed Silverman

STAT Plus: U.S. judge orders Minnesota to pause its drug pricing transparency law over constitutional issues

First Opinion Thomas Farley

STAT Plus: Big Weed today is a whole lot like Big Tobacco in the 1950s

Pharmalot Ed Silverman and John Wilkerson

STAT Plus: A growing number of U.S. states, cities, and counties are suing insulin makers and PBMs

First Opinion Emily Freeman

Ohio has enshrined the right to an abortion. But major obstacles remain for patients and providers

Pharmalot Ed Silverman

STAT Plus: Michigan bill that would pare back pharma liability shield law moves closer to enactment